NCT06757023 A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
| NCT ID | NCT06757023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Xiamen University |
| Condition | Postoperative Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 110 participants |
| Start Date | 2024-11-13 |
| Primary Completion | 2026-10-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 110 participants in total. It began in 2024-11-13 with a primary completion date of 2026-10-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To understand the impact of thumb-tack needle therapy on postoperative sleep and recovery in patients who have undergone general anesthesia, and to explore the clinical significance of thumb-tack needle therapy in improving postoperative sleep quality, preventing postoperative sleep disorders, and promoting postoperative recovery
Eligibility Criteria
Inclusion Criteria: 1. Patients undergoing breast cancer surgery with general anesthesia in the hospital; 2. American Society of Anesthesiologists (ASA) classification I-II; 3. Women aged 18-55 years; 4. No history of chronic insomnia; 5. Individuals who have not taken sedative-hypnotic drugs within the past month. Exclusion Criteria: 1. Those who do not meet the aforementioned inclusion criteria; 2. A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.); 3. A history of sleep disorders and psychiatric history; 4. Inability to receive thumb-tack needle treatment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06757023 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Postoperative Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06757023 currently recruiting?
Yes, NCT06757023 is actively recruiting participants. Contact the research team at yangbin4332@outlook.com for enrollment information.
Where is the NCT06757023 trial being conducted?
This trial is being conducted at Xiamen, China, Xiamen, China.
Who is sponsoring the NCT06757023 clinical trial?
NCT06757023 is sponsored by The First Affiliated Hospital of Xiamen University. The trial plans to enroll 110 participants.